Barden Capital Management’s Colgate-Palmolive CL Stock Holding History

Barden Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	+12,798	New	+$1.12M	1.08%	31

Other funds holding CL

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Barden Capital Management's CL Position: Q2 2026 in Review

Barden Capital Management opened a new position in Colgate-Palmolive (CL) in Q2 2026: 12,798 shares worth $1.17M. The stake represents 1.08% of the portfolio and ranks #31 among its holdings.

1,171 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Barden Capital Management held 12,798 shares of Colgate-Palmolive worth $1.17M as of Q2 2026.
Colgate-Palmolive was a new Barden Capital Management position in Q2 2026.
Colgate-Palmolive made up 1.08% of Barden Capital Management's portfolio in Q2 2026, its #31 holding.
1,171 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Barden Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.